Imperative Care news
Imperative Care, Inc. announced today that the first patient has been enrolled in the Imperative Trial. This prospective, multi-center clinical trial is the first study designed to evaluate the clinical benefits of direct aspiration for the treatment of ischemic stroke with the Zoom 88 Large Distal Platform, which is currently FDA cleared for neurovascular access. Additionally, the trial will gather data on the clinical benefits of the full Zoom Stroke Solution™, the company&rsquo
- Holly Sheffield, Medical Technology Executive and Investment Banker
- Hank Plain, Serial Entrepreneur, Executive and Venture Capital Leader
- James Rogers, Public and Private Medical Technology Investor
Imperative Care, Inc. today announced three appointments to the company’s Board of Directors with the addition of Holly Sheffield, Hank Plain, and James Rogers.
“We are gr
Imperative Care, Inc. today announced that it has closed a $260 million Series D financing led by D1 Capital Partners L.P. New investors HealthCor Investments LLC and Innovatus Capital Partners, LLC also joined the
Imperative Care, Inc., a company singularly dedicated to answering unsolved problems in stroke, today announced that Matthew Garrett has been appointed as the company’s Chief Financial Officer. Mr. Garrett is a seasoned fina
Imperative Care, Inc., a company singularly dedicated to addressing unsolved problems in stroke, today announced that its Chief Operating Officer, Daniel Davis, has been appointed as the company’s President. Mr. Davis will o
Imperative Care, Inc. today announced that it has completed the initial closing of a Series C financing of $85 million to support the commercial launch of the company’s portfolio, which is composed of the latest advances in neurovascular devices treating ischemic and hemorrhagic strokes.
The round was co-led by new investors Ally Bridge Group and Bain Capital Life Sciences. Existing Imperative Care investors Ascension Ventures, Delos Capital, Rock Springs Capital, 3
Imperative Care, Inc., a company singularly dedicated to answering unsolved problems in stroke, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ZOOM™ Aspiration System – a family of products designed to facilitate clot removal during ischemic stroke.
The ZOOM Aspiration System includes the ZOOM Reperfusion Catheters, ZOOM Aspiration Pump, ZOOM Canister, and the ZOOM Aspiration Tubing. The ZOOM Reperfusion Cathete
Imperative Care, Inc., a company singularly dedicated to finding answers to unsolved problems in stroke, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its first family of access catheters, designed to deliver interventional treatments during minimally invasive neurovascular procedures for aneurysms, stroke and other brain blood vessel conditions.
“Recognizing the significant need to elevate the standard of patient therapeutics in stroke